Isolation and anti-HIV-1 integrase activity of lentzeosides A–F from extremotolerant lentzea sp. H45, a strain isolated from a high-altitude Atacama Desert soil by Wichner, Dominik et al.
 UWS Academic Portal
Isolation and anti-HIV-1 integrase activity of lentzeosides A–F from extremotolerant
lentzea sp. H45, a strain isolated from a high-altitude Atacama Desert soil
Wichner, Dominik; Idris, Hamidah; Houssen, Wael E. ; McEwan, Andrew R.; Bull, Alan T.; A
Asenjo, Juan; Goodfellow, Michael; Jaspars, Marcel; Ebel, Rainer; Rateb, Mostafa
Published in:
The Journal of Antibiotics
DOI:
10.1038/ja.2016.78
E-pub ahead of print: 29/06/2016
Document Version
Peer reviewed version
Link to publication on the UWS Academic Portal
Citation for published version (APA):
Wichner, D., Idris, H., Houssen, W. E., McEwan, A. R., Bull, A. T., A Asenjo, J., ... Rateb, M. (2016). Isolation
and anti-HIV-1 integrase activity of lentzeosides A–F from extremotolerant lentzea sp. H45, a strain isolated from
a high-altitude Atacama Desert soil. The Journal of Antibiotics. https://doi.org/10.1038/ja.2016.78
General rights
Copyright and moral rights for the publications made accessible in the UWS Academic Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
Take down policy
If you believe that this document breaches copyright please contact pure@uws.ac.uk providing details, and we will remove access to the
work immediately and investigate your claim.
Download date: 17 Sep 2019
1 
 
Isolation and Anti-HIV-1 Integrase Activity of Lentzeosides A-F from Extremotolerant 1 
Lentzea sp. H45, a strain isolated from a high altitude Atacama Desert soil 2 
Running head: Lentzeosides A-F from Extremotolerant Lentzea sp. H45 3 
Dominik Wichner,1,9 Hamidah Idris,2 Wael E. Houssen,1,4,8
 
Andrew R. McEwan,1,4 Alan T. Bull,5 4 
Juan A. Asenjo,7 Michael Goodfellow,2 Marcel Jaspars,1 Rainer Ebel,1 and Mostafa E. Rateb,1,3,6,* 5 
1
 Marine Biodiscovery Centre, University of Aberdeen, Aberdeen AB24 3UE, Scotland, UK. 6 
2
 School of Biology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK. 7 
3
 School of Science & Sport, University of the West of Scotland, Paisley PA1 2BE, UK.   8 
4
 Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK. 9 
5 School of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, U.K. 10 
6
 Pharmacognosy Department, School of Pharmacy, Beni-Suef University, Beni-Suef 32514, Egypt.  11 
7
 Centre for Biotechnology and Bioengineering (CeBiB), Department of Chemical Engineering and 12 
Biotechnology, Universidad de Chile, Beauchef 851, Santiago 8370450, Chile. 13 
8
 Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. 14 
9
 University of Regensburg, Universitätsstraße 31, Regensburg 93053, Germany. 15 
 16 
  17 
The extremotolerant isolate H45 was one of several actinomycetes isolated from a high altitude 18 
Atacama Desert soil collected in northwest Chile. The isolate was identified as a new Lentzea sp. 19 
using a combination of chemotaxonomic, morphological and phylogenetic properties. Large scale 20 
fermentation of the strain in two different media followed by chromatographic purification led to 21 
the isolation of six new diene and monoene glycosides named lentzeosides A–F, together with the 22 
known compound (Z)-3-hexenyl glucoside. The structures of the new compounds were confirmed 23 
by HRESIMS and NMR analyses. Compounds 1-6 displayed moderate inhibitory activity against 24 
HIV integrase. 25 
* Correspondence: Mostafa E. Rateb, E-mail: mostafa.rateb@uws.ac.uk, Tel: +4414418483072   26 
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 INTRODUCTION 1 
Natural products are known to be a rich source of diverse chemical scaffolds for drug discovery. 2 
However, their use has diminished in the past two decades, mainly due to technical barriers when 3 
screening natural products in high-throughput assays against molecular targets and to their limited 4 
availability for clinical trials.1 Additionally, the discovery of new bioactive natural products is 5 
challenging due to the high rate of re-discovery of known metabolites, a problem that can be 6 
addressed by isolating and screening novel microorganisms from underexplored habitats, such as 7 
desert biomes2,3, and by incorporating rigorous dereplication procedures into all stages of the 8 
discovery process. In addition, industry has realized that phenotypic screening is more effective at 9 
discovering new bioactive compounds than narrow screening of molecular targets.  10 
The Atacama Desert in Chile is known for its extreme aridity which has persisted for at least ∼15 11 
million years.4 Some regions in the desert were once thought to have “Mars-like” soils deemed too 12 
extreme for life to exist given high levels of UV radiation, the presence of inorganic oxidants, areas 13 
of high salinity, and very low concentrations of organic carbon.5  However, recent research has 14 
revealed extraordinary bacterial diversity across a range of Atacama environments6,7, and many 15 
novel actinomycetes have been isolated from hyper – and extreme hyper-arid soils.8,9  Biological 16 
and genome-guided screening of some of these actinomycetes has led to the isolation and 17 
characterization of new natural products belonging to diverse structural classes and exhibiting 18 
various biological activities, as exemplified by the antimicrobial chaxamycins and chaxalactins 19 
isolated from Streptomyces leeuwenhoekii C34T, the abenquines from Streptomyces sp. DB634, the 20 
antitumor atacamycins from Streptomyces sp. C38, and the cell invasion inhibitor chaxapeptin from 21 
S. leeuwenhoekii strain C58.10-16  22 
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As part of our ongoing program to investigate the extremobiosphere as a source of new natural 1 
products, we have focused our attention on Lentzea sp. strain H45 which was isolated from a high 2 
altitude Atacama Desert soil and shown to produce a specific pattern of secondary metabolites 3 
based on its LCMS profile and associated NMR data. Chemical screening of the strain on two 4 
different cultivation media led to the isolation of six new and one known diene, as well as monoene 5 
glycosides (Figure 1). Structure elucidation of these compounds was based on HRESIMS, 1D and 6 
2D NMR analyses. The isolated compounds were screened for their inhibitory activity against HIV-7 
1 integrase, an enzyme that is critical for the integration of the HIV genome into the host genome.17 8 
This target is very attractive for the development of new anti-HIV therapy as it is selective for the 9 
virus. 10 
RESULTS 11 
In this study, actinobacterial isolate H45 was obtained from subsurface soil sample collected at an 12 
altitude > 5000 m in the vicinity of the ALMA Observatory in the Atacama Desert, Chile. The 13 
chemotaxonomic, morphological, physiological and phylogenetic properties of strain H45 are in 14 
line with its classification in the genus Lentzea.18,19 The strain was found to be an aerobic, Gram-15 
positive actinomycete that formed a branched substrate mycelium and aerial hyphae that 16 
fragmented into rod-shaped elements (Figure 2), while chemical analysis of whole-organism 17 
hydrolysates revealed the presence of meso-diaminopimelic acid and galactose, mannose and 18 
ribose, and the predominant isoprenologue was tetrahydrogenated menaquinone with nine isoprene 19 
units (MK9[H4]). The organism formed a distinct branch at the periphery of the Lentzea 16S rRNA 20 
gene tree, a position that was supported by all of the tree-making algorithms and by a 69% bootstrap 21 
value (Figure 3).  The strain was most closely, albeit loosely, related to Lentzea kentuckyensisT 22 
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NRRL B-34416.  These results clearly show that the isolate forms a new centre of taxonomic 1 
variation in the genus Lentzea consistent with its recognition as a putative new species. 2 
Large scale fermentation of Lentzea sp. strain H45 on two different media supplemented with 3 
Diaion HP-20 resin was followed by methanolic extraction of the resin beads; subsequently, the 4 
crude extract was subject to multiple steps of medium and high pressure preparative C-18 5 
chromatography which resulted in the isolation of six new and one known natural product based 6 
on HRESIMS and NMR data (Figure 1).  7 
HRESIMS analysis of compound 1 yielded a [M+Na]+ ion at m/z 281.1351 indicating a molecular 8 
formula of C13H22O5. The analysis of 1H, 13C and multiplicity-edited HSQC NMR spectra revealed 9 
the presence of one methylene (δC/δH 20.5/2.16) and one oxymethylene group (δC/δH 68.3/4.26, 10 
4.08), one methyl doublet (δC/δH 17.9/1.15), one methyl triplet (δC/δH 14.2/0.94), four olefinic 11 
resonances (δC/δH 133.7/5.42, 129.6/5.71, 127.4/5.94, 127.0/6.58) and five oxymethine groups 12 
(δC/δH 102.1/4.15, 76.4/3.09, 75.3/2.80, 73.7/2.98, 71.5/3.15). Furthermore, the 1H NMR spectrum 13 
showed 3 hydroxy groups resonating at δH 4.8-5.1. The COSY correlations of H2-1 through H3-7 14 
indicated a spin system comprising two conjugated olefins with a terminal ethyl group and 15 
established a (2E,4Z)-heptadien-1-ol substructure (Figure 4). This was corroborated by the HMBC 16 
correlations of H2-1/C-3, H-2/C-4, and H3-7 to both C-5 and C-6 (Figure 4). The COSY spectrum 17 
indicated a second spin system which included the signals H-1' to H3-6', which in combination with 18 
the HMBC correlation of H-1'/C-5' suggested a β-L-quinovopyranose (β-L-6-19 
deoxyglucopyranose), which was confirmed by the optical rotation, the coupling constant of the 20 
anomeric proton (J = 7.8 Hz), axial-axial proton couplings for H1'/H2', H2'/H3', H3'/H4', H4'/H5' 21 
(Table 2) as well as the agreement of the 13C NMR data and the ROESY correlations with reported 22 
data.20 The sugar moiety was further confirmed by acid hydrolysis of 1 upon which α-L-quinovose 23 
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was detected by co-chromatography on TLC in comparison with authentic sugar samples. Finally, 1 
the connectivity of the two substructures was confirmed by the HMBC correlation of H-1'/C-1. 2 
The geometry of the two double bonds was established as (2E,4Z) based on coupling constant data 3 
of H-2 and H-5 with values of 16.1 Hz and 10.1 Hz, respectively which was further supported by 4 
ROESY correlations of H-2/H-4, H-3/H2-1, H-4/H-5 and H-3/H2-6 (Figure 4). Based on this 5 
evidence, 1 was identified as a new natural product for which the name lentzeoside A is proposed.  6 
Compound 2 shared the chemical formula with 1 as C13H22O5 based on the HRESIMS analysis that 7 
gave an [M+Na]+ ion at m/z 281.1351. Comparison of the 1H and 13C NMR data of 2 with those 8 
obtained for 1 revealed that 2 was the 1'-epimer of 1, and the presence of an α-L-rhamnopyranose 9 
was corroborated by the optical rotation, the very small coupling of the anomeric proton and the 10 
agreement of the 13C NMR data and the ROESY correlations with the reported data.21 The sugar 11 
moiety was further confirmed by acid hydrolysis of 2 upon which α-L-rhamnose was detected by 12 
co-chromatography on TLC in comparison with authentic sugar samples. Thus, compound 2 was 13 
identified as a new secondary metabolite for which we propose the name lentzeoside B.   14 
The molecular formula C13H22O6 for compound 3 was established on the basis of HRESIMS 15 
analysis that afforded an [M+Na]+ ion at m/z 297.1299 indicating one more oxygen atom than in 16 
1. The 1H, 13C NMR and multiplicity-edited HSQC spectra showed a close similarity to those 17 
obtained for 1, but indicated that the β-L-rhamnopyranose unit in 1 had been replaced by a 18 
β-D-glucopyranose. This assumption was confirmed by the optical rotation, the maganitude of the 19 
coupling constant analysis of the anomeric proton (J=7.9 Hz) as well as the agreement of the 13C 20 
NMR data and the ROESY correlations with the reported data.22 The sugar moiety was further 21 
confirmed by acid hydrolysis of 3 upon which β-D-glucose was detected by co-chromatography 22 
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on TLC in comparison with authentic sugar samples. Therefore, the structure of 3 was established 1 
as depicted, representing a new natural product for which the name lentzeoside C is proposed.   2 
The HRESIMS analysis of compound 4 provided a [M+Na]+ ion at m/z 281.1349 indicating it to 3 
be an isomer of 2. Analysis of the NMR spectra and the optical rotation indicated that the two 4 
compounds contained a α-L-rhamnopyranose, but differed in the geometry of the diene moiety. 5 
The coupling constant data of H-2 and H-5 with values of 16.1 Hz and 15.5 Hz, respectively 6 
indicated E-configurations for both olefinic groups in 4. This was further supported by the ROESY 7 
correlations of H2-1/H-3, H-3/H-5, H-2/H-4 and H-4/H2-6 (Figure 4). On that basis, 4 was 8 
identified as a new secondary metabolite for which the name lentzeoside D is proposed.   9 
The molecular formula of compounds 5 and 6 was deduced as C12H22O5 as HRESIMS analysis of 10 
[M+Na]+ and [M+H]+ ions at m/z 269.1351 and 247.1545, respectively indicating one carbon atom 11 
less than 1. NMR analysis and optical rotation of 5 and 6 indicated that they contained an 12 
α-L-rhamnopyranose and a β-L-quinovopyranose as described above for 2 and 1, respectively, 13 
which was connected to the same (Z)-3-hexenyl side chain. The presence of the latter was evident 14 
from COSY correlations of H2-1 through H3-6. As the signals for H-3 and H-4 exhibited non-first 15 
order coupling, the E-configuration of the double bond was established based on ROESY 16 
correlations of H2-1/H-3, H-4/H3-6 and H2-2/H2-5 (Figure 4). Based on this information, 17 
compounds 5 and 6 were identified as new natural products for which the names lentzeoside E and 18 
F, respectively, are proposed.   19 
Based on the NMR and accurate mass analyses, compound 7 was identified as (Z)-3-hexenyl 20 
glucoside, this compound has been isolated from several plant sources, such as Epimedium 21 
grandiflorum.23   22 
7 
 
Compounds 1-6 were evaluated for their anti-HIV integrase activity at different concentrations. 1 
Compounds 3, 4 and 5 inhibited HIV integrase with IC50 values of 21 µM, 16 µM and 21 µM 2 
respectively. Compounds 1, 2 and 6 were only weakly active, they did not give 50 % inhibition of 3 
the enzyme activity up to a concentration of 100 µM.  4 
DISCUSSION 5 
A major draw of filamentous actinomycetes, especially streptomycetes, is their unrivalled capacity 6 
to synthesize structurally diverse bioactive metabolites.  In this context, the present study provides 7 
further evidence that taxonomically novel actinomycetes isolated from Atacama Desert soils are a 8 
rich source of new chemical entities. It is especially interesting that the new compounds, 9 
lentzosides A-F, are derived from a novel Lentzia strain as previously new specialized metabolites 10 
from Atacama Desert actinomycetes have come from novel Streptomyces strains,7 notably from a 11 
deep seated 16S rRNA gene clade that can be equated with the species, Streptomyces 12 
leeuwenhoekii.10-16  The genus Lentzia was validly published in 1995,24 but to date does not appear 13 
to have been studied in terms of its natural product chemistry, though Lentzia sp. 7887 effects the 14 
biotransformation of FR901459, a novel derivative of cyclosporin.25  15 
Chemical screening of this novel Lentzia sp. strain H45 on two different media led to the isolation 16 
of six new diene and monoene glycosides and the known compound (Z)-3-hexenyl glucoside. It is 17 
interesting to note that this class of metabolites was not traced before from microbial sources and 18 
the most closely related known compound 7 which was also encountered in the present study had 19 
previously been obtained from plant sources. Due to the close similarity of lentzeosides, it could 20 
be argued that they were artifacts rather than natural products. To preclude this assumption and 21 
confirm them as natural products, they were directly detected by LCMS analysis of the fresh 22 
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bacterial culture broth before the inclusion of the Diaion HP20, extraction and purification process 1 
with the exact retention times, UV absorption and accurate mass.  2 
Compounds 1-6 were found to inhibit HIV-1 integrase in vitro.  Treatment of HIV usually involves 3 
a combination therapy of different drugs that target different stages of the viral replication cycle, a 4 
procedure that overcomes the development of resistance in the virus due to its high mutation rate26. 5 
HIV integrase is one of the key enzymes in the virus replication cycle as it is responsible for the 6 
integration of the reverse transcribed viral cDNA into the host cell genome.27 Raltegravir® is the 7 
first FDA clinically approved HIV integrase inhibitor used to treat both HIV-1 infections in 8 
treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains 9 
resistant to multiple antiretroviral agents.28  10 
EXPERIMENTAL PROCEDURES 11 
General Experimental Procedures. NMR data were acquired on a Varian VNMRS 600 MHz NMR 12 
spectrometer and LC-HRESIMS data obtained by using a LTQ/XL Orbitrap coupled to the HPLC 13 
system (PDA detector, PDA autosampler, and pump) under the following conditions: capillary 14 
voltage of 45 V, capillary temperature of 260 °C, auxiliary gas flow rate of 10−20 arbitrary units, 15 
sheath gas flow rate of 40−50 arbitrary units, spray voltage of 4.5 kV with a mass range of 16 
100−2000 amu (maximal resolution of 30000). For LC/MS, a C18 analytical HPLC column (5 µm, 17 
4.6 mm × 150 mm) was used with a mobile phase of 0 to 100% MeOH over 30 min at a flow rate 18 
of 1 mL.min−1. Optical rotations were recorded using a Bellingham + Stanley ADP410 polarimeter. 19 
Medium Pressure Liquid Chromatographic separations were carried out using a Biotage SP1 flash 20 
system fitted with a reversed phase 40iM cartridge (KP-C18-HSTM, 40 x 150 mm), the detection 21 
was carried out at 220 and 254 nm. For RP-HPLC separations, a SunFire (C18, 250 x 10 mm, 5 µm 22 
i.d.) column connected to an Agilent 1200 series binary pump was used and monitored with an 23 
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Agilent photodiode array detector, the detection was carried out at 220, 254, 280, and 320 nm. Acid 1 
hydrolysis of the isolated compounds was performed as reported before.29 HPLC solvents and the 2 
authentic sugar samples were obtained from Sigma-Aldrich, the ingredients for fermentation were 3 
from Oxoid UK and Sigma-Aldrich and the Diaion HP-20 resin from Resindion S.R.L., a 4 
subsidiary of Mitsubishi Chemical Co., Binasco, Italy. 5 
Microbial taxonomy and fermentation conditions. Strain H45 was isolated from a subsurface soil 6 
sample collected at 5048 meters above sea level on the Chajnantor plateau, in northeast Chile 7 
(23o00’48.8”S/67o45’30.8”W) by one of us (MG) in November 2012. The strain was isolated on 8 
Gauze’s No. 1 agar30 supplemented with the antifungal antibiotics cycloheximide and nystatin 9 
(each at 25 µg.mL-1) using the procedure described by Okoro et al.8 The strain has phenotypic 10 
properties consistent with its classification in the genus Lentzea and forms a distinct phyletic line 11 
in the Lentzea 16S rRNA gene tree. The Lentzea isolate has been deposited in the NCIMB and 12 
NRRL public service collections under the accession numbers 14966 and B-65282 respectively, 13 
the GenBank accession number of the 16S rRNA gene sequence of the strain is LT009512. Two 14 
cultivation media were used for large scale fermentation of the strain: Medium 410 contained 15 
glucose (10.0 g), glycerol (10.0 g), casamino acids (15.0 g), oatmeal (5.0 g), peptone (10.0 g), 16 
yeast extract (5.0 g), CaCO3 (1.0 g) and distilled water to 1 L, pH 7.0; and modified ISP2 medium 17 
malt extract (4.0 g), yeast extract (10.0 g), dextrose (10.0 g), glycerol (10.0 g), and distilled water 18 
to 1 L, pH 7.0. The strain was grown in 4 L of each of these media by shaking at 180 rpm in a 19 
shaker incubator at 30 °C for 7 days when HP-20 resin beads was added followed by shaking at 20 
180 rpm for 6 h prior to centrifugation at 3000 rpm for 15 min. 21 
Extraction and isolation. Biomass of the strain H45 and HP-20 resin beads were extracted with 22 
methanol (MeOH × 2) and acetone (×1) and the resultant extracts combined and concentrated in 23 
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vacuo. The combined extracts were purified using the Biotage flash system with a gradient of 1 
MeOH in water (5-100% in 12 column volumes). The eluted fractions of both media were screened 2 
using LCMS and 1H NMR and the interesting fractions further purified using RP-HPLC. For 3 
medium 410, the second fraction was purified using a gradient of MeOH in H2O/MeOH (95:5) 4 
(25-100% in 25 min, flow rate 2.0 mL/min) to obtain compounds 1 (3.1 mg), 2 (1.0 mg), 3 5 
(2.2 mg), 4 (1.0 mg), and 5 (2.0 mg). In the case of the modified ISP2 medium, the fourth fraction 6 
was purified using a gradient of MeOH in H2O/MeOH (95:5) (50-100% in 25 min, flow rate 7 
2.2 mL/min) to obtain compounds 1 (3.1 mg), 2 (1.1 mg), 5 (3.4 mg), 6 (3.4 mg), and 7 (2.2 mg). 8 
Lentzeoside A (1): Light yellow powder; [α]20D –25 (c 0.15, MeOH); UV (MeOH) λmax (log ɛ) at 9 
258 (3.2), 268 (3.6) and 280 (2.7) nm; 1H and 13C NMR data (Tables 1-2); HRESIMS m/z [M+Na]+ 10 
at 281.1351 indicting the molecular formula C13H22O5 (calculated [M+Na]+ ion at m/z 281.1359). 11 
Lentzeoside B (2): Light yellow powder; [α]20D –31 (c 0.18, MeOH); UV (MeOH) λmax (log ɛ) at 12 
258 (3.1), 270 (3.4) and 280 (2.5) nm; 1H and 13C NMR data (Tables 1-2); HRESIMS m/z [M+Na]+ 13 
at 281.1351 indicting the molecular formula C13H22O5 (calculated [M+Na]+ ion at m/z 281.1359). 14 
Lentzeoside C (3): Light yellow powder; [α]20D +38 (c 0.10, MeOH); UV (MeOH) λmax (log ɛ) at 15 
258 (3.2), 274 (3.8) and 282 (2.9) nm; 1H and 13C NMR data (Tables 1-2); HRESIMS m/z [M+Na]+ 16 
at 297.1299 indicting the molecular formula C13H22O6 (calculated [M+Na]+ ion at m/z 297.1309). 17 
Lentzeoside D (4): Light yellow powder; [α]20D –22 (c 0.18, MeOH); UV (MeOH) λmax (log ɛ) at 18 
258 (3.1), 270 (3.4) and 280 (2.5) nm; 1H and 13C NMR data (Tables 1-2); HRESIMS m/z [M+Na]+ 19 
at 281.1349 indicting the molecular formula C13H22O5 (calculated [M+Na]+ ion at m/z 281.1359). 20 
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Lentzeoside E (5): colorless powder; [α]20D –29 (c 0.15, MeOH); UV (MeOH) λmax (log ɛ) at 239 1 
(3.6) nm; 1H and 13C NMR data (Tables 1-2); HRESIMS m/z [M+Na]+ at 269.1351 indicting the 2 
molecular formula C12H22O5 (calculated [M+Na]+ ion at m/z 269.1359). 3 
Lentzeoside F (6): colorless powder; [α]20D –25 (c 0.18, MeOH); UV (MeOH) λmax (log ɛ) at 241 4 
(3.4) nm; 1H and 13C NMR data (Tables 1-2); HRESIMS m/z [M+H]+ at 247.1545 indicting the 5 
molecular formula C12H22O5 (calculated [M+H]+ ion at m/z 247.1540). 6 
Anti-HIV-1 integrase activity. The HIV-1 integrase inhibitory activities of compounds 1-6 were 7 
evaluated using a kit purchased from XpressBio Life Science Products (Frederick, MD 21705, 8 
USA) and by following the manufacturer’s protocol.  Briefly, biotin-linked HIV-1 LTR U5 donor 9 
substrate (DS) DNA was applied to a streptavidin-coated 96-well plate, the test compounds were 10 
then added along with target substrate DNA and HIV integrase. The integrase processes the HIV-1 11 
LTR U5 and catalyzes the strand transfer recombination reaction to integrate the DS DNA into the 12 
target substrate DNA. The products of these reactions were detected colorimetrically using an 13 
HRP-labeled antibody, sodium azide was used as a positive inhibitory control. Each compound 14 
was tested at 4 different concentrations (100, 50, 12.5 and 3.1 µM) in triplicate. 15 
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Figure legends 1 
Figure 1. Compounds isolated from Lentzea sp. H45. 2 
Figure 2. Scanning electron micrograph of Lentzea sp. H45 showing fragmentation of aerial 3 
hyphae into rod-shaped elements following growth on ISP 3 agar after incubation at 28 °C for 10 4 
days. Bar 1µm. 5 
Figure 3. Neighbour-joining phylogenetic tree based on 16S rRNA gene sequences showing 6 
relationships between isolate H45 and the type strains of Lentzea and Lechevalieria species. 7 
Asterisks indicate branches of the tree that were also recovered using the maximum-likelihood and 8 
maximum-parsimony tree-making methods. Numbers at the nodes indicate levels of bootstrap 9 
support based on a neighbour-joining analysis of 1000 resampled datasets, only values above 50% 10 
are shown.  11 
Figure 4. Key COSY, HMBC and ROESY correlations of compounds 1, 4, and 5. 12 
 13 
 14 
 15 
 16 
 17 
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Figure 1. Compounds isolated from Lentzea sp. H45. 2 
 3 
Figure 2. Scanning electron micrograph of Lentzea sp. H45 showing fragmentation of aerial 4 
hyphae into rod-shaped elements following growth on ISP 3 agar after incubation at 28 °C for 10 5 
days. Bar 1µm. 6 
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 1 
Figure 3. Neighbour-joining phylogenetic tree based on 16S rRNA gene sequences showing 2 
relationships between isolate H45 and the type strains of Lentzea and Lechevalieria species. 3 
Asterisks indicate branches of the tree that were also recovered using the maximum-likelihood and 4 
maximum-parsimony tree-making methods. Numbers at the nodes indicate levels of bootstrap 5 
support based on a neighbour-joining analysis of 1000 resampled datasets, only values above 50% 6 
are shown. 7 
 8 
Figure 4. Key COSY ( ), HMBC ( ) and ROESY ( ) correlations of 9 
compounds 1, 4, and 5. 10 
 11 
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Lentzea violacea IMSNU 50388T(AJ242633 )
Lentzea flaviverrucosa AS4.0578T (AF183957)
Lentzea californiensis NRRL B-16137T(AF174435)
Lentzea albida IFO 16102T(AB006176)
Lentzea waywayandensis NRRL B-16159T(AB020029)
Lentzea kentuckyensis NRRL B-24416T(DQ291145)
Lentzea guizhouensis DHS C013T(KM597488)
Lentzea jiangxiensis FXJ1.034T(FJ938354)
Isolate H45 (LT009512)
Lechevalieria fradiae Z6T(AY114175)
Actinosynnema mirum DSM 43827T(CP001630)
Actinosynnema pretiosum subsp. auranticum NBRC 15620T(AB303364)
Lechevalieria aerocolonigenes NRRL B-3298T(JOHF101000104)
Lechevalieria flava NRRL B-16131T(AF114808)
Lechevalieria nigeriaca NJ2035T(JN989291)
Lechevalieria xinjiangensis R24T(DQ898283)
Lechevalieria atacamensis C61T(EU551684)
Lechevalieria deserti C68T(EU551682)
Lechevalieria roselyniae C81T(EU551683)
Actinokineospora mzabensis PAL84T(KJ504177)
Amycolatopsis orientalis DSM 40040T(ASJB01000052)
82
85
99
100
79
97
100
82
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0.005 *
*
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*
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Table 1. 13C (150 MHz) NMR spectroscopic data for lentzeosides A–F (1-6) in DMSO-d6 1 
Position 1 2 3 4 5 6 
δC, mult. δC, mult. δC, mult. δC, mult. δC, mult. δC, mult. 
1 68.3, CH2 66.5, CH2 68.2, CH2 68.3, CH2 66.1, CH2 68.2, CH2 
2 129.6, CH 129.5, CH 129.6, CH 127.1, CH 27.2, CH 27.6, CH 
3 127.0, CH 127.2, CH 127.1, CH 132.5, CH 125.4, CH 125.2, CH 
4 127.4, CH 127.3, CH 127.4, CH 128.5, CH 133.0, CH 132.9, CH 
5 133.7, CH 133.9, CH 133.7, CH 136.5, CH 20.1, CH2 20.1, CH2 
6 20.5, CH2 20.5, CH2 20.5, CH2 25.0, CH2 14.2, CH3 14.2, CH3 
7 14.2, CH3 14.1, CH3 14.2, CH3 13.4, CH2   
1' 102.1, CH 99.3, CH 102.0, CH 99.1, CH 99.9, CH 102.7, CH 
2' 73.7, CH 70.7, CH 73.5, CH 70.7, CH 70.7, CH 73.6, CH 
3' 76.4, CH 70.5, CH 76.7, CH 70.5, CH 70.5, CH 76.5, CH 
4' 75.3, CH 72.0, CH 68.2, CH 72.0, CH 72.0, CH 75.3, CH 
5' 71.5, CH 68.5, CH 76.9, CH 68.5, CH 68.4, CH 71.5, CH 
6' 17.9, CH3 17.9, CH3 61.1, CH2 17.9, CH3 17.9, CH3 17.9, CH3 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
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Table 2. 1H (600 MHz) NMR spectroscopic data for lentzeosides A–F (1-6) in DMSO-d6  1 
Position 1 2 3 4 5 6 
δH, mult. (J in Hz) δH, mult. (J in Hz) δH, mult. (J in Hz) δH, mult. (J in Hz) δH, mult. (J in Hz) δH, mult. (J in Hz) 
1 4.26 (dd, 13.2, 5.4) 
4.08 (dd, 13.1, 5.2) 
4.11 (dd, 12.9, 5.3) 
3.97 (dd, 12.7, 5.2) 
4.32 (dd, 13.7, 5.8) 
4.10 (dd, 13.6, 6.5) 
4.06 (dd, 12.2, 5.3) 
3.91 (dd, 12.4, 5.1) 
3.51 (m) 3.66 (m) 
3.42 (m) 
2 5.71 (dt, 16.1, 6.3) 5.73 (dt, 15.9, 6.1) 5.73 (dt, 15.7, 5.9) 5.63 (dt, 16.1, 5.8) 2.24 (m) 2.26 (m) 
3 6.58 (t, 14.5) 6.51 (t, 14.2) 6.59 (dd, 15.2, 11.2) 6.18 (t, 15.3) 5.32 (m) 5.33 (m) 
4 5.94 (t, 11.2) 5.96 (t, 11.3) 5.96 (t, 11.1) 6.04 (t, 15.1) 5.42 (m) 5.42 (m) 
5 5.42 (dt, 10.1, 6.7) 5.43 (dt, 10.5, 6.2) 5.42 (dt, 10.9, 6.5) 5.75 (dt, 15.5, 6.5) 2.01 (m) 2.01 (m) 
6 2.16 (m) 2.16 (m) 2.16 (m) 2.07 (m) 0.92 (t, 7.6) 0.92 (t, 7.6) 
7 0.94 (t, 7.5) 0.95 (t, 7.5) 0.94 (t, 7.5) 0.96 (t, 7.4)   
1' 4.15 (d, 7.8) 4.57 (br s) 4.15 (d, 7.9) 4.56 (br s) 4.54 (br s) 4.12 (d, 7.8) 
2' 2.98 (t, 7.5) 3.41 (m) 2.97 (m) 3.40 (m) 3.39 (m) 2.94 (t, 7.9) 
3' 3.09 (t, 8.6) 3.60 (br s) 3.12 (t, 7.6) 3.59 (br s) 3.57 (br s) 3.08 (t, 8.8) 
4' 2.80 (t, 7.6) 3.18 (m) 3.04 (m) 3.17 (m) 3.17 (t, 8.9) 2.79 (t, 8.6) 
5' 3.15 (m) 3.38 (m) 3.05 (m) 3.38 (m) 3.37 (m) 3.15 (m) 
6' 1.15 (d, 6.1) 1.14 (d, 6.4) 3.66 (dd, 11.5, 5.6) 
3.43 (m) 
1.13 (d, 6.1) 1.12 (d, 6.3) 1.14 (d, 6.3) 
OH-2' 5.07 (br s)  5.08 (d, 4.4) 4.74 (br s) 4.72 (br s) 4.91 (d, 18.1) 
OH-3' 4.96 (br s)  4.91 (d, 3.9)  4.51 (br s) 4.94 (br s) 
OH-4' 4.96 (br s)  4.96 (br s) 4.47 (br s) 4.70 (br s) 4.91 (br s) 
OH-6'    4.49 (t, 5.7)    
 2 
